UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

JAMA : the journal of the American Medical Association, 2007-07, Vol.298 (4), p.405

2007

Volltextzugriff (PDF)

Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study

Heart rhythm, 2022-05, Vol.19 (5), p.782-789

2022

Volltextzugriff (PDF)

Relation of 12-Lead Electrocardiogram Patterns to Implanted Defibrillator-Terminated Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy

The American journal of cardiology, 2009-12, Vol.104 (12), p.1722-1726

2009

Volltextzugriff (PDF)

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators

Circulation. Arrhythmia and electrophysiology, 2018-04, Vol.11 (4), p.e005820-e005820

2018

Volltextzugriff (PDF)

Ventricular Arrhythmia Inducibility Predicts Subsequent ICD Activation in Nonischemic Cardiomyopathy Patients: A DEFINITE Substudy

Pacing and clinical electrophysiology, 2009-06, Vol.32 (6), p.755-761

2009

Volltextzugriff (PDF)

Clinical Significance of J Waves in Patients Undergoing Therapeutic Hypothermia for Out‐of‐Hospital Cardiac Arrest

Pacing and clinical electrophysiology, 2017-02, Vol.40 (2), p.154-161

2017

Volltextzugriff (PDF)

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Circulation (New York, N.Y.), 2006-02, Vol.113 (6), p.776-782

2006

Volltextzugriff (PDF)

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients

Heart rhythm, 2008-11, Vol.5 (11), p.1517-1522

2008

Volltextzugriff (PDF)

Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

JACC. Clinical electrophysiology, 2022-11, Vol.8 (11), p.1417-1427

2022

Volltextzugriff (PDF)

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)

Journal of the American College of Cardiology, 2002-11, Vol.40 (9), p.1703-1719

2002

Volltextzugriff (PDF)

Cost Avoidance Utilizing a Batching Process for Isoproterenol

P&T (Lawrenceville, N.J.), 2016-09, Vol.41 (9), p.560-561

2016

Volltextzugriff (PDF)

The role of the Heart Rhythm Society in Integrating the Healthcare Enterprise

Heart rhythm, 2007, Vol.4 (1), p.122-124

2007

Volltextzugriff (PDF)

Electrophysiology Testing and the National Cardiovascular Data Registry: Stimulating, yet Inconclusive

Pacing and clinical electrophysiology, 2012-08, Vol.35 (8), p.909-911

2012

Volltextzugriff (PDF)

ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)

Journal of cardiovascular electrophysiology, 2002-11, Vol.13 (11), p.1183-1199

2002

Volltextzugriff (PDF)

Inappropriate Defibrillator Shocks from Depolarization—Repolarization Mismatch in a Patient with Hypertrophy Cardiomyopathy

Pacing and clinical electrophysiology, 2007-11, Vol.30 (11), p.1408-1411

2007

Volltextzugriff (PDF)

Utility and Safety of Axillo-subclavian Venous Imaging with Carbon Dioxide (CO2) Prior to Chronic Lead System Revisions

Pacing and clinical electrophysiology, 2010-07, Vol.33 (7), p.790-794

2010

Volltextzugriff (PDF)

Abstract P556: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis

Circulation (New York, N.Y.), 2023-02, Vol.147 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract 10951: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Abstract 15961: Multicenter Prospective Prevention of Sudden Death in High Risk Patients Utilizing Enhanced ACC/AHA Risk Model

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A15961-A15961

2020

Volltextzugriff (PDF)

Nonsustained Polymorphous Ventricular Tachycardia During Amiodarone Therapy for Atrial Fibrillation Complicating Cardiomyopathy

Chest, 1997-05, Vol.111 (5), p.1454-1457

1997

Volltextzugriff (PDF)

B-PO03-072 REDUCTION IN VENTRICULAR TACHYARRHYTHMIA BURDEN IN PATIENTS ENROLLED IN THE RANOLAZINE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (RAID) TRIAL

Heart rhythm, 2021-08, Vol.18 (8), p.S217-S218

2021

Volltextzugriff (PDF)

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and holter monitoring

Journal of the American College of Cardiology, 1987-08, Vol.10 (2), p.349-357

1987

Volltextzugriff (PDF)

Angiographie morphology and the pathogenesis of unstable angina pectoris

Journal of the American College of Cardiology, 1985-03, Vol.5 (3), p.609-616

1985

Volltextzugriff (PDF)

The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study

Journal of the American College of Cardiology, 1989-02, Vol.13 (2), p.377-384

1989

Volltextzugriff (PDF)

1 – 25 von 268

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(230)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy

Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study

Relation of 12-Lead Electrocardiogram Patterns to Implanted Defibrillator-Terminated Ventricular Tachyarrhythmias in Hypertrophic Cardiomyopathy

Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators

Ventricular Arrhythmia Inducibility Predicts Subsequent ICD Activation in Nonischemic Cardiomyopathy Patients: A DEFINITE Substudy

Clinical Significance of J Waves in Patients Undergoing Therapeutic Hypothermia for Out‐of‐Hospital Cardiac Arrest

Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?

Safety and efficacy of transvenous high-voltage implantable cardioverter-defibrillator leads in high-risk hypertrophic cardiomyopathy patients

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)

Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy

ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)

Cost Avoidance Utilizing a Batching Process for Isoproterenol

The role of the Heart Rhythm Society in Integrating the Healthcare Enterprise

Electrophysiology Testing and the National Cardiovascular Data Registry: Stimulating, yet Inconclusive

ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines)

Inappropriate Defibrillator Shocks from Depolarization—Repolarization Mismatch in a Patient with Hypertrophy Cardiomyopathy

Utility and Safety of Axillo-subclavian Venous Imaging with Carbon Dioxide (CO2) Prior to Chronic Lead System Revisions

Abstract P556: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis

Abstract 10951: Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Meta-Analysis

Abstract 15961: Multicenter Prospective Prevention of Sudden Death in High Risk Patients Utilizing Enhanced ACC/AHA Risk Model

Nonsustained Polymorphous Ventricular Tachycardia During Amiodarone Therapy for Atrial Fibrillation Complicating Cardiomyopathy

B-PO03-072 REDUCTION IN VENTRICULAR TACHYARRHYTHMIA BURDEN IN PATIENTS ENROLLED IN THE RANOLAZINE IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR (RAID) TRIAL

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: Based on signal-averaged electrocardiogram, radionuclide ejection fraction and holter monitoring

Angiographie morphology and the pathogenesis of unstable angina pectoris

The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study

Suchergebnisse filtern